Tag Archives: vasomotor
10
Feb
How African American Patients Are Affected By Vasomotor Symptoms
African American women experience menopause within a broader context of biological, social, and stru...
16
Dec
Practical Strategies for Integrating NK Receptor Antagonism for Vasomotor Symptoms into Primary Care
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
16
Dec
Final Thoughts on Vasomotor Symptoms and NK Receptor Antagonism
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
09
Dec
Beyond Vasomotor Symptoms: The Potential Role of NK Receptor Antagonism in Mood and Sleep
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
09
Dec
Positioning NK Receptor Antagonism in the Vasomotor Symptoms Treatment Landscape
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
02
Dec
Evaluating the Rapid Onset of Vasomotor Symptom Improvement and Safety Profiles of NK Receptor Antagonists
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
02
Dec
Exploring the Broader Therapeutic Potential of NK1 Receptor Antagonists Beyond Vasomotor Symptoms
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women with Breast Cancer Receiving Endocrine Therapy
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...